FindTrial
Sign In

A ramdomized, double-binded clinical trial comparison of two dimensions of traditional medical precision medicine for allergic rhinitis: Syndrome differentiation-based treatment or staging treatment?

Clinical Observation on Treatment of Allergic Rhinitis with Deficiency of Lung and Spleen Qi by Stages

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053605
Enrollment
Unknown
Registered
2021-11-25
Start date
2018-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Syndrome differentiation-based treatment :Syndrome differentiation-based treatment
staging treatment:staging treatment

Sponsors

Shenzhen Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 68 Years

Inclusion criteria

Inclusion criteria: The inclusion of the participants followed diagnostic criteria for allergic rhinitis as defined by the Chinese guidelines for allergic rhinitis 2015. Only patients with age 18 years or older and Chinese ethnicity were included.

Exclusion criteria

Exclusion criteria: Patients that have been treated in the past three months, or with any basic diseases of long-term medication (such as hypertension, serious diabetes, or any serious heart disease) or ongoing treatment for serious chronic diseases (such as cancer) were excluded. Patients that have other medication during the 1-year follow-up period were withdrawn.

Design outcomes

Primary

MeasureTime frame
Quantitative Score of Allergic Rhinitis Symptoms;Allergic rhinitis body qualitative score;—

Countries

China

Contacts

Public ContactWenyang Fu

Shenzhen Traditional Chinese Medicine Hospital

fuwenyang@163.com+86 18682167325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026